Alzheimer-specific epitope of AT100 in transfected cell lines with tau: Toward an efficient cell model of tau abnormal phosphorylation

Neuroscience Letters

Volumn 255, Issue 1, 1998, Pages 13-16

  Mailliot, Christel ^a   Bussière, Thierry ^a   Caillet Boudin, Marie Laure ^a   Delacourte, André ^a   Buée, Luc ^a  

^a INSERM   (France)

Author keywords

Alzheimer's disease; COS cells; Phosphorylation; SY5Y neuroblastoma cells; Tau protein; Transfection

Indexed keywords

OKADAIC ACID; TAU PROTEIN;

ALPHA HELIX; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL TYPE; EXON; GENETIC TRANSFECTION; IMMUNOREACTIVITY; NERVE DEGENERATION; NEUROBLASTOMA CELL; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION;

ALZHEIMER DISEASE; ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE, TRANSFORMED; COS CELLS; DNA, COMPLEMENTARY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITOPES; OKADAIC ACID; PHOSPHORYLATION; TAU PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032500861     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00693-4     Document Type: Article

References (21)

1. Buée-Scherrer V., Condamines O., Mourton-Gilles C., Jakes R., Goedert M., Pau B., Delacourte A. AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. Mol. Brain Res. 39:1996;79-88.
2. Caillet-Boudin M.L., Delacourte A. Phosphorylated Ser422, a specific Alzheimer epitope is expressed by SKNSH-SY5Y cells after okadaic acid. NeuroReport. 8:1996;307-310.
3. Delacourte A., Buée L. Normal and pathological tau proteins as factors for microtubule assembly. Int. Rev. Cytol. 171:1997;167-224.
4. Goedert M., Hasegawa M., Jakes R., Lawler S., Cuenda A., Cohen P. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. FEBS Lett. 409:1997;57-62.
5. Goedert M., Spillantini M.G., Jakes R., Rutherford D., Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles. Neuron. 3:1989;519-526.
6. Gong C.X., Shaikh S., Wang J.Z., Zaidi T., Grundke-Iqbal I., Iqbal K. Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer's disease. J. Neurochem. 65:1995;732-738.
7. Hasegawa M., Jakes R., Crowther R.A., Lee V.M.Y., Ihara Y., Goedert M. Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against tau proteins. FEBS Lett. 384:1996;25-30.
8. Ho D.T., Shayan H., Murphy T.H. Okadaic acid induces hyperphosphorylation of tau independently of mitogen-activated protein kinase activation. J. Neurochem. 68:1997;106-111.
9. Hoffmann R., Lee V.M.Y., Leight S., Varga I., Otvos L. Jr. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites. Biochemistry. 36:1997;8114-8124.
10. Hong M., Lee V.M.Y. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J. Biol. Chem. 272:1997;19547-19553.
11. Matsuo E.S., Shin R.W., Billingsley M.L., Van de Voorde A., O'Connor M., Trojanowski J.Q., Lee V.M.Y. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron. 13:1994;989-1002.
12. Mawal-Dewan M., Henley J., Van de Voorde A., Trojanowski J.Q., Lee V.M.Y. The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases. J. Biol. Chem. 269:1994;30981-30987.
13. Medina M., Montejo de Garcini E., Avila J. The role of tau phosphorylation in transfected COS-1 cells. Mol. Cell Biochem. 148:1995;79-88.
14. Mulot S.F.C., Hughes K., Woodgett J.R., Anderton B.H., Hanger D.P. PHF-Tau from Alzheimer's brain comprises four species on SDS-PAGE which can be mimicked by an in vitro phosphorylation of human brain tau by glycogen synthase kinase-3β FEBS Lett. 349:1994;359-364.
15. Munoz-Montano J.R., Moreno F.J., Avila J., Diaz-Nido J. Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons. FEBS Lett. 411:1997;183-188.
16. Sergeant N., Bussière T., Vermersch P., Lejeune J.P., Delacourte A. Isoelectric point differentiates PHF-Tau from biopsy-derived human brain Tau proteins. NeuroReport. 6:1995;2217-2220.
17. Sergeant N., David J.P., Goedert M., Jakes R., Vermersch P., Buée L., Lefranc D., Wattez A., Delacourte A. Two-dimensional characterization of paired helical filament-Tau from Alzheimer's disease: demonstration of an additional 74 kDa component and age-related biochemical modifications. J. Neurochem. 69:1997;834-844.
18. Shea T.B., Fisher I. Phosphatase inhibition in human neuroblastoma cells alters tau antigenicity and renders it incompetent to associate with exogenous microtubules. FEBS Lett. 380:1996;63-67.
19. Vincent I., Rosado M., Davies P. Mitotic mechanisms in Alzheimer's disease? J. Cell Biol. 132:1996;413-425.
20. Wadzinski B.E., Wheat W.H., Jaspers S., Peruski L.F. Jr., Lickteig R.L., Johnson G.L., Klemm D.J. Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation. Mol. Cell Biol. 13:1993;2822-2834.
21. Zheng-Fischhöfer Q., Biernat J., Mandelkow E.M., Illenberger S., Godemann R., Mandelkow E. Sequential phosphorylation of Tau by glycogen synthase kinase-3β and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. Eur. J. Biochem. 252:1998;542-552.